Unpacking Averages: Is It Too Soon to Study the Postmarket Experience of AI-Driven Medical Devices?

Start
I may be jumping the gun here, but I’m anxious to understand how the new flurry of AI medical devices is performing in the marketplace, or more specifically, whether the devices are failing to perform in a way that jeopardizes health….
By: Epstein Becker & Green
Previous Story

Special Health Resources of Texas Files Notice of Data Breach with Federal Government

Next Story

Cyberattack Targeting National Public Data Could Have Leaked Information Belonging to 2.9 Billion People